A federal appellate court has upheld the Drug Enforcement Administration’s denial of a Seattle doctor’s request to use ...

A biotech company is attempting to persuade Kansas legislators to modify the state’s controlled substances act in advance of ...

A federal appellate court has rejected the latest effort by a Washington State doctor who is seeking to legally use psilocybin to treat cancer patients in end-of-life care, ruling that the Drug ...

Positive IHL-42X PK findings for the treatment of Obstructive Sleep Apnea (OSA) support future 505(b)(2) New Drug Application (NDA) submissionNew ...

On February 13, 2025, the Ninth Circuit Court of Appeals affirmed the U.S. Drug Enforcement Administration’s (DEA) decision ...

Psychedelics are categorized as Schedule I under the federal Controlled Substances Act and the DEA defines them as having no ...

Senate Bill 219 which would establish a medical psilocybin program, making New Mexico only the third state to do so, passed its first committee Tuesday.

Small clinical trials have demonstrated the efficacy of psilocybin in making significant improvements in people suffering ...

The Tacoma City Council passed a resolution supporting statewide decriminalization of plant- and fungi-based psychedelics.

An important Senate committee in New Mexico has unanimously advanced legislation to create a program for the medicinal use of ...

From 2014 to 2022, the number of psychiatrists billing Medicare Part B declined, while the total number of active ...

Researchers at CU Anschutz are studying the effect of psychedelic mushrooms on patients with treatment-resistant depression.